Sona Nanotech Inc (TSE:SONA)
:SONA
Want to see TSE:SONA full AI Analyst Report?
SONA Stock Chart & Stats
C$0.40
>-C$0.01(-2.00%)
At close: 4:00 PM EST
C$0.40
>-C$0.01(-2.00%)
Day’s Range― - ―
52-Week RangeC$0.26 - C$0.91
Previous CloseN/A
Volume36.80K
Average Volume (3M)124.26K
Market Cap
C$32.03M
Enterprise ValueC$35.17M
Total Cash (Recent Filing)C$36.55K
Total Debt (Recent Filing)C$318.31K
Price to Earnings (P/E)―
Beta0.86
Next Earnings
Jun 25, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding114,375,250
10 Day Avg. Volume87,178
30 Day Avg. Volume124,263
Financial Highlights & Ratios
PEG Ratio-2.88
Price to Book (P/B)-1.80K
Price to Sales (P/S)0.00
P/FCF Ratio-35.53
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.06
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Proprietary Product FocusSona's focus on proprietary gold nanorods establishes a differentiated product platform in diagnostics and research. A specialized materials IP base can enable durable licensing, reagent supply, or assay integration opportunities if technical validation and adoption progress, supporting long-term revenue pathways.
Low Absolute DebtModest absolute debt reduces fixed financing obligations and lowers near-term insolvency risk relative to highly leveraged peers. If management preserves low debt while progressing commercialization, the company retains more flexibility to raise growth capital without immediate credit strain.
Improving Cash Burn Trend Vs 2021A structural improvement in cash burn versus earlier periods suggests operational progress or cost discipline. If sustained, lower burn narrows future funding needs and lengthens runway, making subsequent commercialization or fundraising less dilutive and enhancing long-term survivability.
Bears Say
No Revenue / No Commercial ScaleThe absence of revenue means the business model has not been validated commercially; product-market fit and customer adoption remain unproven. Long-term viability thus depends on converting R&D into sustainable sales, which requires time, capital, and successful regulatory/market execution.
Negative Shareholders' EquityNegative equity signals accumulated losses have eroded the capital base, reducing financial flexibility and creditor confidence. This structural weakness constrains borrowing capacity, increases refinancing risk, and raises the likelihood of dilutive equity raises to fund operations over the medium term.
Persistent Cash Burn & Negative FCFSustained negative operating and free cash flow indicates ongoing reliance on external financing. Over months, continued cash deficits force fundraising or cost cuts, which can dilute shareholders or impede R&D/commercialization progress, threatening the company's ability to reach self-sustaining operations.
Sona Nanotech Inc News
SONA FAQ
What was Sona Nanotech Inc’s price range in the past 12 months?
Sona Nanotech Inc lowest stock price was C$0.26 and its highest was C$0.91 in the past 12 months.
What is Sona Nanotech Inc’s market cap?
Sona Nanotech Inc’s market cap is C$32.03M.
When is Sona Nanotech Inc’s upcoming earnings report date?
Sona Nanotech Inc’s upcoming earnings report date is Jun 25, 2026 which is in 11 days.
How were Sona Nanotech Inc’s earnings last quarter?
Currently, no data Available
Is Sona Nanotech Inc overvalued?
According to Wall Street analysts Sona Nanotech Inc’s price is currently Overvalued.
Does Sona Nanotech Inc pay dividends?
Sona Nanotech Inc does not currently pay dividends.
What is Sona Nanotech Inc’s EPS estimate?
Sona Nanotech Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Sona Nanotech Inc have?
Sona Nanotech Inc has 114,375,250 shares outstanding.
What happened to Sona Nanotech Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Sona Nanotech Inc?
Currently, no hedge funds are holding shares in TSE:SONA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Sona Nanotech Inc
Based in Halifax, Canada, Sona Nanotech Inc. is a life sciences company focused on nanotechnology. It develops and commercializes gold nanorod solutions primarily for diagnostic applications. Their product portfolio includes the Nanotech COVID-19 Lateral Flow Assay, an immunochromatographic test designed to detect the SARS-CoV-2 spike protein antigen in saliva from individuals suspected of having the virus. The company also offers Gemini and Omni gold nanorods, with the latter specifically engineered for medical uses, in addition to providing contract services. These versatile products are utilized in a wide array of applications, such as targeted drug delivery, environmental and food safety monitoring, cellular visualization, cancer therapy, liposuction treatments, and diagnostic tools for medical, consumer, military, and veterinary sectors.
Technical Analysis
BioMark Diagnostics
―
Eastwood Bio-Medical Canada
―
StageZero Life Sciences Ltd
―
Medmira
―
ZYUS Life Sciences
―
Options Prices
Currently, No data available
---